Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction

被引:56
作者
Pilz, Patrick M. [1 ,2 ]
Ward, Jennifer E. [3 ]
Chang, Wei-Ting
Kiss, Attila [2 ]
Bateh, Edward [1 ]
Jha, Alokkumar
Fisch, Sudeshna [3 ]
Podesser, Bruno K. [2 ]
Liao, Ronglih [1 ,3 ]
机构
[1] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA
[2] Med Univ Vienna, Ludwig Boltzmann Inst, Ctr Biomed Res, Vienna, Austria
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
heart failure; hypertrophy; ischemia; reperfusion; MYOCARDIAL-INFARCTION; MOUSE MODEL; PRESSURE-OVERLOAD; SEX-DIFFERENCES; DILATED CARDIOMYOPATHY; VENTRICULAR-FUNCTION; CARDIAC-HYPERTROPHY; ATRIAL-FIBRILLATION; SURGICAL THERAPY; PIG MODEL;
D O I
10.1161/CIRCRESAHA.122.320246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) describes a heterogenous complex spectrum of pathological conditions that results in structural and functional remodeling leading to subsequent impairment of cardiac function, including either systolic dysfunction, diastolic dysfunction, or both. Several factors chronically lead to HF, including cardiac volume and pressure overload that may result from hypertension, valvular lesions, acute, or chronic ischemic injuries. Major forms of HF include hypertrophic, dilated, and restrictive cardiomyopathy. The severity of cardiomyopathy can be impacted by other comorbidities such as diabetes or obesity and external stress factors. Age is another major contributor, and the number of patients with HF is rising worldwide in part due to an increase in the aged population. HF can occur with reduced ejection fraction (HF with reduced ejection fraction), that is, the overall cardiac function is compromised, and typically the left ventricular ejection fraction is lower than 40%. In some cases of HF, the ejection fraction is preserved (HF with preserved ejection fraction). Animal models play a critical role in facilitating the understanding of molecular mechanisms of how hearts fail. This review aims to summarize and describe the strengths, limitations, and outcomes of both small and large animal models of HF with reduced ejection fraction that are currently used in basic and translational research. The driving defect is a failure of the heart to adequately supply the tissues with blood due to impaired filling or pumping. An accurate model of HF with reduced ejection fraction would encompass the symptoms (fatigue, dyspnea, exercise intolerance, and edema) along with the pathology (collagen fibrosis, ventricular hypertrophy) and ultimately exhibit a decrease in cardiac output. Although countless experimental studies have been published, no model completely recapitulates the full human disease. Therefore, it is critical to evaluate the strength and weakness of each animal model to allow better selection of what animal models to use to address the scientific question proposed.
引用
收藏
页码:1888 / 1905
页数:18
相关论文
共 146 条
[1]  
[Anonymous], ANN NUMBER ANIMALS U
[2]   Atrial and ventricular fibrosis induced by atrial fibrillation: Evidence to support early rhythm control [J].
Avitall, Boaz ;
Bi, Jian ;
Mykytsey, Andrew ;
Chicos, Alex .
HEART RHYTHM, 2008, 5 (06) :839-845
[3]   Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings [J].
Baris, Veysel Ozgur ;
Gedikli, Esra ;
Yersal, Nilgun ;
Muftuoglu, Sevda ;
Erdem, Aysen .
AMINO ACIDS, 2019, 51 (10-12) :1649-1655
[4]   Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy [J].
Barrick, Cordelia J. ;
Rojas, Mauricio ;
Schoonhoven, Robert ;
Smyth, Susan S. ;
Threadgill, David W. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (05) :H2119-H2130
[5]   CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure [J].
Batkai, Sandor ;
Genschel, Celina ;
Viereck, Janika ;
Rump, Steffen ;
Baer, Christian ;
Borchert, Tobias ;
Traxler, Denise ;
Riesenhuber, Martin ;
Spannbauer, Andreas ;
Lukovic, Dominika ;
Zlabinger, Katrin ;
Hasimbegovic, Ena ;
Winkler, Johannes ;
Garamvolgyi, Rita ;
Neitzel, Sonja ;
Gyoengyoesi, Mariann ;
Thum, Thomas .
EUROPEAN HEART JOURNAL, 2021, 42 (02) :192-201
[6]   A Novel Large Animal Model of Thrombogenic Coronary Microembolization [J].
Bikou, Olympia ;
Tharakan, Serena ;
Yamada, Kelly P. ;
Kariya, Taro ;
Gordon, Alexandra ;
Miyashita, Satoshi ;
Watanabe, Shin ;
Sassi, Yassine ;
Fish, Kenneth ;
Ishikawa, Kiyotake .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2019, 6
[7]  
Bikou O, 2018, METHODS MOL BIOL, V1816, P337, DOI 10.1007/978-1-4939-8597-5_26
[8]  
Bikou O, 2018, METHODS MOL BIOL, V1816, P281, DOI 10.1007/978-1-4939-8597-5_22
[9]   A mouse model of reverse cardiac remodelling following banding-debanding of the ascending aorta [J].
Bjornstad, J. L. ;
Skrbic, B. ;
Sjaastad, I. ;
Bjornstad, S. ;
Christensen, G. ;
Tonnessen, T. .
ACTA PHYSIOLOGICA, 2012, 205 (01) :92-102
[10]   Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration [J].
Blom, Jessica N. ;
Lu, Xiangru ;
Arnold, Paul ;
Feng, Qingping .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (111)